Found: 29
Select item for more details and to access through your institution.
Practice variation in re-resection for recurrent glioblastoma: A nationwide survey among Dutch neuro-oncology specialists.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 4, p. 360, doi. 10.1093/nop/npad016
- By:
- Publication type:
- Article
Evaluation of an online tool about the expected course of disease for glioblastoma patients—A qualitative study.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 5, p. 411, doi. 10.1093/nop/npac033
- By:
- Publication type:
- Article
Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 4, p. 310, doi. 10.1093/nop/npac022
- By:
- Publication type:
- Article
Worries and needs of adults and parents of adults with neurofibromatosis type 1.
- Published in:
- American Journal of Medical Genetics. Part A, 2018, v. 176, n. 5, p. 1150, doi. 10.1002/ajmg.a.38680
- By:
- Publication type:
- Article
Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2023.1119159
- By:
- Publication type:
- Article
Preoperative Classification of Peripheral Nerve Sheath Tumors on MRI Using Radiomics.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2039, doi. 10.3390/cancers16112039
- By:
- Publication type:
- Article
Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1.
- Published in:
- Journal of Attention Disorders, 2022, v. 26, n. 4, p. 563, doi. 10.1177/10870547211012035
- By:
- Publication type:
- Article
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 9, p. 1547, doi. 10.1093/neuonc/noab088
- By:
- Publication type:
- Article
A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 4, p. 557, doi. 10.1093/neuonc/noaa280
- By:
- Publication type:
- Article
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab--a report from the BELOB trial.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 853, doi. 10.1093/neuonc/now311
- By:
- Publication type:
- Article
Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 5, p. 719, doi. 10.1093/neuonc/now194
- By:
- Publication type:
- Article
Are we done with dose-intense temozolomide in recurrent glioblastoma?
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 9, p. 1161, doi. 10.1093/neuonc/nou157
- By:
- Publication type:
- Article
A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 3, p. 344, doi. 10.1093/neuonc/nor221
- By:
- Publication type:
- Article
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 2, p. 235
- By:
- Publication type:
- Article
Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 8, p. 1639, doi. 10.1007/s00520-011-1254-1
- By:
- Publication type:
- Article
Is motor inhibition during laughter due to emotional or respiratory influences?
- Published in:
- Psychophysiology, 2004, v. 41, n. 2, p. 254, doi. 10.1111/j.1469-8986.2003.00145.x
- By:
- Publication type:
- Article
Rare central nervous system tumors in adults: a population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac062
- By:
- Publication type:
- Article
The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac032
- By:
- Publication type:
- Article
Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.
- Published in:
- Journal of Patient-Reported Outcomes, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41687-024-00732-w
- By:
- Publication type:
- Article
The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.
- Published in:
- Journal of Patient-Reported Outcomes, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41687-024-00714-y
- By:
- Publication type:
- Article
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
- Published in:
- Acta Neuropathologica, 2021, v. 141, n. 6, p. 945, doi. 10.1007/s00401-021-02291-6
- By:
- Publication type:
- Article
Diagnostic value of <sup>18</sup>F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 156, n. 3, p. 559, doi. 10.1007/s11060-021-03936-y
- By:
- Publication type:
- Article
Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 365, doi. 10.1007/s11060-014-1641-9
- By:
- Publication type:
- Article
Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 108, n. 1, p. 195, doi. 10.1007/s11060-012-0832-5
- By:
- Publication type:
- Article
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.
- Published in:
- Journal of Neuro-Oncology, 2011, v. 101, n. 3, p. 405, doi. 10.1007/s11060-010-0274-x
- By:
- Publication type:
- Article
High‐yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing.
- Published in:
- Human Mutation, 2022, v. 43, n. 12, p. 2130, doi. 10.1002/humu.24487
- By:
- Publication type:
- Article
Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 326, doi. 10.1093/neuonc/noab258
- By:
- Publication type:
- Article
Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183155
- By:
- Publication type:
- Article